BioAge Labs BIOA Income Statement (2023-2026)

NASDAQ BIOA
$10.12 -0.63 (-5.86%)
At close: Aug 20, 2026 · 10:50 AM UTC
Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 1.67M1.67M1.67M1.72M3.49M10.73M35.85M35.85M35.85M37.39M44.39M45.90M
Revenue & cost
Revenue (Quarter) 1.45M2.41M2.05M3.08M2.77M2.45M
Gross Profit (Quarter) -4.61M-4.68M-14.48M-13.36M-3.18M-11.54M-10.19M-15.54M-10.37M-14.23M
Operating items
Research & Development (Quarter) 6.53M10.08M9.32M10.47M20.02M19.23M11.11M19.84M18.51M24.50M20.41M24.36M
Selling, General & Administrative (Quarter) 3.35M3.51M3.49M4.80M4.73M6.14M6.79M7.34M6.68M7.00M7.74M7.42M
Operating Expenses (Quarter) 9.89M13.60M12.81M15.27M24.75M25.36M17.90M27.18M25.19M31.50M28.15M31.78M
Operating Income (Quarter) -9.89M-13.60M-12.81M-15.27M-24.75M-25.36M-16.45M-24.77M-23.14M-28.42M-25.38M-29.33M
EBIT (Quarter) -9.89M-13.60M-12.81M-15.27M-24.75M-25.36M-16.45M-24.77M-23.14M-28.42M-25.38M-29.33M
Non-operating items
Interest & Investment Income (Quarter) 0.50M0.38M2.04M-5.53M3.71M0.07M12.98M3.27M3.44M
Other Non Operating Income (Quarter) -0.25M
Non Operating Income (Quarter) -4.74M-7.36M-0.18M1.69M1.34M4.23M3.52M3.21M2.97M2.48M3.12M3.24M
Net income details
EBT (Quarter) -11.79M-15.78M-14.03M-15.71M-82.20M-31.21M-13.03M-25.56M-28.55M-15.71M-22.21M-157.61M
Profit After Tax (Quarter) -14.62M-20.96M-12.99M-13.58M-23.35M-21.10M-12.93M-21.56M-20.17M-80.64M-22.25M-26.65M
Income from Continuing Operations (Quarter) -11.79M-15.78M-14.03M-15.71M-82.20M-31.21M-13.03M-25.56M-28.55M-15.71M-22.21M-157.61M
Consolidated Net Income (Quarter) -11.79M-15.78M-14.03M-15.71M-82.20M-31.21M-13.03M-25.56M-28.55M-15.71M-22.21M-157.61M
Income towards Parent Company (Quarter) -11.79M-15.78M-14.03M-15.71M-82.20M-31.21M-13.03M-25.56M-28.55M-15.71M-22.21M-157.61M
Net Income towards Common Stockholders (Quarter) -11.79M-15.78M-14.03M-15.71M-82.20M-31.21M-13.03M-25.56M-28.55M-15.71M-22.21M-157.61M
Additional items
EPS (Basic) (Quarter) -7.05-9.43-8.38-9.18-23.52-2.91-0.36-0.71-0.80-0.44-0.52-3.52
EPS (Diluted) (Quarter) -7.05-9.43-8.38-9.18-23.52-2.91-0.36-0.71-0.80-0.44-0.52-3.52
Shares Outstanding (Quarter) 1.67M1.67M1.67M1.71M3.49M10.73M35.85M35.85M35.85M35.93M42.48M44.84M
Shares Outstanding (Diluted) (Quarter) 1.67M1.67M1.67M1.71M3.49M10.73M35.85M35.85M35.85M35.93M42.48M44.84M
EBITDA (Quarter) -9.89M-13.60M-12.81M-15.27M-24.75M-25.36M-16.45M-24.77M-23.14M-28.42M-25.38M-29.33M
Interest Expenses (Quarter) 2.40M2.56M1.22M0.44M59.49M0.32M0.30M0.79M5.49M0.27M0.10M131.72M